BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 32816730)

  • 1. Rifabutin Is Bactericidal against Intracellular and Extracellular Forms of Mycobacterium abscessus.
    Johansen MD; Daher W; Roquet-Banères F; Raynaud C; Alcaraz M; Maurer FP; Kremer L
    Antimicrob Agents Chemother; 2020 Oct; 64(11):. PubMed ID: 32816730
    [No Abstract]   [Full Text] [Related]  

  • 2. Activity of Rifabutin and Hemi-synthetic Derivatives Against Mycobacterium abscessus.
    Ramis IB; Figueiredo R; Ramos DF; Halicki PCB; von Groll A; Viveiros M; do Ceu Costa M; da Silva PEA
    Med Chem; 2018; 14(4):394-399. PubMed ID: 29205119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bedaquiline Inhibits the ATP Synthase in Mycobacterium abscessus and Is Effective in Infected Zebrafish.
    Dupont C; Viljoen A; Thomas S; Roquet-Banères F; Herrmann JL; Pethe K; Kremer L
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28807917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of rifabutin against Mycobacterium abscessus, clinical isolates.
    Chen J; Zhang H; Guo Q; He S; Xu L; Zhang Z; Ma J; Chu H
    Clin Exp Pharmacol Physiol; 2022 Jul; 49(7):767-775. PubMed ID: 35531776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rifabutin Is Active against Mycobacterium abscessus Complex.
    Aziz DB; Low JL; Wu ML; Gengenbacher M; Teo JWP; Dartois V; Dick T
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28396540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rifabutin Acts in Synergy and Is Bactericidal with Frontline Mycobacterium abscessus Antibiotics Clarithromycin and Tigecycline, Suggesting a Potent Treatment Combination.
    Pryjma M; Burian J; Thompson CJ
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29760147
    [No Abstract]   [Full Text] [Related]  

  • 7. ADP-ribosylation-resistant rifabutin analogs show improved bactericidal activity against drug-tolerant
    Xie M; Ganapathy US; Lan T; Osiecki P; Sarathy JP; Dartois V; Aldrich CC; Dick T
    Antimicrob Agents Chemother; 2023 Sep; 67(9):e0038123. PubMed ID: 37493373
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Cheng A; Tsai YT; Chang SY; Sun HY; Wu UI; Sheng WH; Chen YC; Chang SC
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30670428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rifabutin Is Active against Mycobacterium abscessus in Mice.
    Dick T; Shin SJ; Koh WJ; Dartois V; Gengenbacher M
    Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31767722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential
    Lee J; Ammerman N; Agarwal A; Naji M; Li SY; Nuermberger E
    Antimicrob Agents Chemother; 2021 Jan; 65(2):. PubMed ID: 33168614
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Fujiwara K; Aono A; Asami T; Morimoto K; Kamada K; Morishige Y; Igarashi Y; Chikamatsu K; Murase Y; Yamada H; Takaki A; Mitarai S
    Antimicrob Agents Chemother; 2023 Jun; 67(6):e0157922. PubMed ID: 37154742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repositioning rifamycins for Mycobacterium abscessus lung disease.
    Ganapathy US; Dartois V; Dick T
    Expert Opin Drug Discov; 2019 Sep; 14(9):867-878. PubMed ID: 31195849
    [No Abstract]   [Full Text] [Related]  

  • 13.
    Le Run E; Arthur M; Mainardi JL
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29866869
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Le Run E; Arthur M; Mainardi JL
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30745387
    [No Abstract]   [Full Text] [Related]  

  • 15. Thiostrepton: A Novel Therapeutic Drug Candidate for
    Kim TH; Hanh BTB; Kim G; Lee DG; Park JW; Lee SE; Kim JS; Kim BS; Ryoo S; Jo EK; Jang J
    Molecules; 2019 Dec; 24(24):. PubMed ID: 31835481
    [No Abstract]   [Full Text] [Related]  

  • 16. Arabinosyltransferase C Mediates Multiple Drugs Intrinsic Resistance by Altering Cell Envelope Permeability in Mycobacterium abscessus.
    Wang S; Cai X; Yu W; Zeng S; Zhang J; Guo L; Gao Y; Lu Z; Hameed HMA; Fang C; Tian X; Yusuf B; Chhotaray C; Alam MDS; Zhang B; Ge H; Maslov DA; Cook GM; Peng J; Lin Y; Zhong N; Zhang G; Zhang T
    Microbiol Spectr; 2022 Aug; 10(4):e0276321. PubMed ID: 35946941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlling Extra- and Intramacrophagic
    Viljoen A; Herrmann JL; Onajole OK; Stec J; Kozikowski AP; Kremer L
    Front Cell Infect Microbiol; 2017; 7():388. PubMed ID: 28920054
    [No Abstract]   [Full Text] [Related]  

  • 18. Combined Host- and Pathogen-Directed Therapy for the Control of Mycobacterium abscessus Infection.
    Poerio N; Riva C; Olimpieri T; Rossi M; Lorè NI; De Santis F; Henrici De Angelis L; Ciciriello F; D'Andrea MM; Lucidi V; Cirillo DM; Fraziano M
    Microbiol Spectr; 2022 Feb; 10(1):e0254621. PubMed ID: 35080463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potency of Omadacycline against Mycobacteroides abscessus Clinical Isolates
    Nicklas DA; Maggioncalda EC; Story-Roller E; Eichelman B; Tabor C; Serio AW; Keepers TR; Chitra S; Lamichhane G
    Antimicrob Agents Chemother; 2022 Jan; 66(1):e0170421. PubMed ID: 34662184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternative and Experimental Therapies of
    Meir M; Barkan D
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32948001
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.